LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 39 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,487,000 | -23.8% | 1,500,000 | 0.0% | 0.50% | -23.8% |
| Q1 2021 | $1,951,000 | +35.9% | 1,500,000 | 0.0% | 0.66% | +8.9% |
| Q4 2020 | $1,436,000 | +4.9% | 1,500,000 | 0.0% | 0.61% | -16.3% |
| Q3 2020 | $1,369,000 | +4.7% | 1,500,000 | 0.0% | 0.73% | -15.8% |
| Q2 2020 | $1,308,000 | +4.6% | 1,500,000 | 0.0% | 0.86% | -32.7% |
| Q1 2020 | $1,250,000 | – | 1,500,000 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $39,863,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,837,000 | 1.32% |
| Penn Mutual Asset Management | 810 | $806,000 | 0.86% |
| WOLVERINE ASSET MANAGEMENT LLC | 47,643,000 | $47,931,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,750,000 | 0.25% |
| OAKTREE CAPITAL MANAGEMENT LP | 18,672,000 | $18,683,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,833,000 | $9,883,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,956,000 | 0.15% |
| SSI INVESTMENT MANAGEMENT LLC | 2,500,000 | $2,490,000 | 0.15% |
| AVIVA PLC | 31,500,000 | $31,724,000 | 0.13% |